Univasc

Univasc is a brand name of moexipril, approved by the FDA in the following formulation(s):

UNIVASC (moexipril hydrochloride - tablet; oral)

• 
  Manufacturer: UCB INC
  
  Approval date: April 19, 1995
  
  Strength(s): 15MG ^[RLD][AB], 7.5MG ^[AB]

Has a generic version of Univasc been approved?

Yes. The following products are equivalent to Univasc:

moexipril hydrochloride tablet; oral

• 
  Manufacturer: APOTEX INC
  
  Approval date: June 2, 2008
  
  Strength(s): 15MG ^[AB], 7.5MG ^[AB]


• 
  Manufacturer: GLENMARK GENERICS
  
  Approval date: March 30, 2010
  
  Strength(s): 15MG ^[AB], 7.5MG ^[AB]


• 
  Manufacturer: PADDOCK LLC
  
  Approval date: November 30, 2006
  
  Strength(s): 15MG ^[AB], 7.5MG ^[AB]


• 
  Manufacturer: TEVA
  
  Approval date: May 8, 2003
  
  Strength(s): 15MG ^[AB], 7.5MG ^[AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Univasc. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Univasc.

See also...

• Univasc Consumer Information (Wolters Kluwer)
• Univasc Consumer Information (Cerner Multum)
• Univasc Advanced Consumer Information (Micromedex)
• Univasc AHFS DI Monographs (ASHP)
• Moexipril Consumer Information (Wolters Kluwer)
• Moexipril Consumer Information (Cerner Multum)
• Moexipril Advanced Consumer Information (Micromedex)
• Moexipril Hydrochloride AHFS DI Monographs (ASHP)